Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy (PREVENT)

Protocol No

GI-IIT-STEIN-PREVENT

Staff Member

Daniel Stein

Phase

N/A

Summary

This project is being done to determine whether the use of ursodiol will reduce the recurrence rate of C.Diff infection in patients who have this infection and at least one risk factor for recurrence of C.Diff infection.

Objective

Prevention of Recurrence of C. Difficile Colitis With UCDA as a Supplement to Standard Therapy

Status

OPEN TO ACCRUAL